<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Whitley JA</submitter><funding>NEI NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>e12196</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8982324</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(4)</volume><pubmed_abstract>CRISPR/Cas9 genome editing is a very promising avenue for the treatment of a variety of genetic diseases. However, it is still very challenging to encapsulate CRISPR/Cas9 machinery for delivery. Protein N-myristoylation is an irreversible co/post-translational modification that results in the covalent attachment of the myristoyl-group to the N-terminus of a target protein. It serves as an anchor for a protein to associate with the cell membrane and determines its intracellular trafficking and activity. Extracellular vesicles (EVs) are secreted vesicles that mediate cell-cell communication. In this study, we demonstrate that myristoylated proteins were preferentially encapsulated into EVs. The octapeptide derived from the leading sequence of the N-terminus of Src kinase was a favourable sub</pubmed_abstract><journal>Journal of extracellular vesicles</journal><pubmed_title>Encapsulating Cas9 into extracellular vesicles by protein myristoylation.</pubmed_title><pmcid>PMC8982324</pmcid><funding_grant_id>R21 EY028671</funding_grant_id><funding_grant_id>R01 EY031748</funding_grant_id><funding_grant_id>P30 EY005722</funding_grant_id><funding_grant_id>R21 AI171944</funding_grant_id><funding_grant_id>R21 AI157831</funding_grant_id><funding_grant_id>U01 CA225784</funding_grant_id><pubmed_authors>Desrochers EG</pubmed_authors><pubmed_authors>Xie ZR</pubmed_authors><pubmed_authors>Ye C</pubmed_authors><pubmed_authors>Alsaidan OA</pubmed_authors><pubmed_authors>Sulejmani E</pubmed_authors><pubmed_authors>Cai J</pubmed_authors><pubmed_authors>Cai H</pubmed_authors><pubmed_authors>Kim S</pubmed_authors><pubmed_authors>Whitley JA</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Beharry Z</pubmed_authors><pubmed_authors>Klingeborn M</pubmed_authors><pubmed_authors>Rickman CB</pubmed_authors><pubmed_authors>Lou L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Encapsulating Cas9 into extracellular vesicles by protein myristoylation.</name><description>CRISPR/Cas9 genome editing is a very promising avenue for the treatment of a variety of genetic diseases. However, it is still very challenging to encapsulate CRISPR/Cas9 machinery for delivery. Protein N-myristoylation is an irreversible co/post-translational modification that results in the covalent attachment of the myristoyl-group to the N-terminus of a target protein. It serves as an anchor for a protein to associate with the cell membrane and determines its intracellular trafficking and activity. Extracellular vesicles (EVs) are secreted vesicles that mediate cell-cell communication. In this study, we demonstrate that myristoylated proteins were preferentially encapsulated into EVs. The octapeptide derived from the leading sequence of the N-terminus of Src kinase was a favourable sub</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2026-05-09T19:22:27.12Z</modification><creation>2025-04-06T03:58:39.81Z</creation></dates><accession>S-EPMC8982324</accession><cross_references><pubmed>35384352</pubmed><doi>10.1002/jev2.12196</doi></cross_references></HashMap>